1. Home
  2. FUNC vs TNXP Comparison

FUNC vs TNXP Comparison

Compare FUNC & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUNC
  • TNXP
  • Stock Information
  • Founded
  • FUNC 1900
  • TNXP 2007
  • Country
  • FUNC United States
  • TNXP United States
  • Employees
  • FUNC N/A
  • TNXP N/A
  • Industry
  • FUNC Major Banks
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUNC Finance
  • TNXP Health Care
  • Exchange
  • FUNC Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • FUNC 202.8M
  • TNXP 207.5M
  • IPO Year
  • FUNC N/A
  • TNXP N/A
  • Fundamental
  • Price
  • FUNC $29.87
  • TNXP $38.06
  • Analyst Decision
  • FUNC
  • TNXP Strong Buy
  • Analyst Count
  • FUNC 0
  • TNXP 2
  • Target Price
  • FUNC N/A
  • TNXP $585.00
  • AVG Volume (30 Days)
  • FUNC 13.3K
  • TNXP 1.3M
  • Earning Date
  • FUNC 07-21-2025
  • TNXP 05-12-2025
  • Dividend Yield
  • FUNC 2.94%
  • TNXP N/A
  • EPS Growth
  • FUNC 61.82
  • TNXP N/A
  • EPS
  • FUNC 3.49
  • TNXP N/A
  • Revenue
  • FUNC $79,403,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • FUNC $14.15
  • TNXP $12.17
  • Revenue Next Year
  • FUNC $7.07
  • TNXP $789.15
  • P/E Ratio
  • FUNC $8.59
  • TNXP N/A
  • Revenue Growth
  • FUNC 14.92
  • TNXP N/A
  • 52 Week Low
  • FUNC $19.17
  • TNXP $6.76
  • 52 Week High
  • FUNC $42.50
  • TNXP $549.12
  • Technical
  • Relative Strength Index (RSI)
  • FUNC 44.53
  • TNXP 70.09
  • Support Level
  • FUNC $29.67
  • TNXP $36.65
  • Resistance Level
  • FUNC $30.50
  • TNXP $42.96
  • Average True Range (ATR)
  • FUNC 0.84
  • TNXP 4.35
  • MACD
  • FUNC -0.18
  • TNXP 1.47
  • Stochastic Oscillator
  • FUNC 12.37
  • TNXP 79.74

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: